Medplus Health Services Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2011 • Discontinuing Operation (Wholesale Cash And Carry Business): 99.9% • Continuing Operation (Pathological Laboratory Services And Clinic Business): 0.1%
AI Sector View
AI GENERATEDConsumer Services
Consumer services have a mixed operating backdrop but strong market sponsorship. Foreign tourist arrivals in India rose 6.0% YoY (2026-06), export of services grew 13.0% YoY (2026-06), and headline tourist arrivals were 584000 (Jun/26), though airport passenger traffic was -2.0% YoY (2026-06). Strong FPI inflow of INR 19847 crore over 3 months to 2026-08-31 supports a Buy stance despite some travel softness.
PROS
- Company is almost debt free
- Company has delivered good sales growth of 66.0% CAGR over last 5 years
- Latest quarter profit grew 29.0% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.04x)
- Stock looks reasonably valued - P/E of 119.3 is below its historical median
- Company generates healthy free cash flow
CONS
- Recent results are weak - TTM profit is down 28.2% versus prior year
- Company has a low return on capital employed of 4.5%
- Company has a low return on equity of 3.1% over last 3 years
- Stock is trading at 7.7x its book value
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| DMART | 3667.65 | 78.22 | 239221.00 | 0.00 | 860.44 | 11.34 | 18794.53 | 14.88 | 18.03 | 7.98 |
| TRENT | 2789.70 | 82.24 | 148761.10 | 0.14 | 518.07 | 21.98 | 5754.71 | 17.84 | 36.73 | 19.45 |
| VMM | 103.30 | 54.26 | 48394.07 | 0.00 | 258.77 | 25.57 | 3727.01 | 18.68 | 19.24 | 14.61 |
| METROBRAND | 953.35 | 63.94 | 25987.63 | 0.63 | 95.26 | -3.58 | 720.36 | 14.66 | 35.77 | 29.85 |
| ABLBL | 83.94 | 58.21 | 10245.06 | 0.60 | 29.02 | 20.62 | 2045.74 | 11.15 | 27.34 | 15.06 |
| PNGJL | 613.45 | 20.26 | 9030.14 | 0.00 | 105.33 | 51.91 | 2412.98 | 40.73 | 21.80 | 7.56 |
| V2RETAIL | 218.55 | 44.61 | 7969.15 | 0.00 | 41.85 | 69.70 | 997.20 | 57.73 | 38.43 | 13.99 |
| MEDPLUS | 658.55 | 37.59 | 7911.63 | 0.00 | 33.17 | -21.67 | 1879.60 | 21.84 | 22.22 | 7.09 |
| AVL | 604.25 | 56.15 | 7803.17 | 0.21 | 77.22 | 39.99 | 1192.68 | 26.85 | 20.82 | 10.44 |
| EMIL | 192.05 | 35.84 | 7389.10 | 0.00 | 120.64 | 458.07 | 2418.95 | 39.07 | 11.84 | 9.88 |
| ETHOSLTD | 2684.65 | 69.15 | 7183.50 | 0.00 | 28.66 | 50.71 | 461.71 | 33.32 | 13.70 | 12.97 |
| VMART | 816.95 | 47.24 | 6500.91 | 0.12 | 47.21 | 40.51 | 1088.81 | 23.00 | 23.56 | 14.75 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72 | 99 | 148 | 148 | 178 | 156 | 177 | 202 | 184 | 206 | 223 | 248 | 223 | |
| 70 | 92 | 137 | 135 | 160 | 139 | 158 | 178 | 160 | 179 | 194 | 221 | 203 | |
| Operating Profit | 2 | 6 | 11 | 13 | 18 | 17 | 19 | 24 | 24 | 27 | 29 | 27 | 20 |
| OPM % | 3.23% | 6.32% | 7.27% | 8.69% | 10.29% | 10.85% | 10.57% | 11.82% | 13.00% | 13.17% | 12.88% | 11.05% | 8.87% |
| 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 7 | 7 | 7 | 7 | 5 | 7 |
| Profit before Tax | -3 | -0 | 4 | 6 | 12 | 10 | 12 | 18 | 18 | 21 | 22 | 23 | 23 |
| Tax % | -0.00% | -0.00% | 24.88% | -56.53% | 20.24% | 19.61% | 22.11% | 21.94% | 23.47% | 24.16% | 24.05% | 27.67% | 24.18% |
| Net Profit | -3 | -0 | 3 | 10 | 9 | 8 | 9 | 14 | 14 | 16 | 17 | 17 | 17 |
| -0.29 | 0.00 | 0.27 | 0.82 | 0.77 | 0.65 | 0.78 | 1.17 | 1.13 | 1.31 | 1.38 | 1.39 | 1.45 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 9 | 10 | 61 | 68 | 146 | 214 | 467 | 713 | 861 | 899 | |
| 4 | 14 | 13 | 86 | 77 | 142 | 208 | 435 | 635 | 753 | 796 | |
| Operating Profit | -2 | -5 | -3 | -25 | -9 | 3 | 6 | 32 | 78 | 107 | 103 |
| OPM % | -89.26% | -51.63% | -36.44% | -41.20% | -12.88% | 2.27% | 2.92% | 6.89% | 10.91% | 12.45% | 11.45% |
| 0 | 1 | 1 | 2 | 2 | 10 | 23 | 7 | 9 | 11 | 11 | |
| Interest | 0 | 12 | 0 | 0 | 1 | 3 | 7 | 8 | 9 | 8 | 8 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 5 | 15 | 24 | 27 | 26 | 27 |
| Profit before Tax | -2 | -16 | -3 | -24 | -9 | 6 | 8 | 7 | 51 | 83 | 89 |
| Tax % | -0.00% | -0.00% | -0.00% | -2.11% | -0.00% | 0.00% | 26.92% | -36.02% | 21.18% | 24.96% | 25.05% |
| Net Profit | -2 | -16 | -3 | -25 | -9 | 6 | 6 | 9 | 40 | 62 | 66 |
| EPS | -115.90 | -934.15 | -132.45 | -11.99 | -0.82 | 0.50 | 0.46 | 0.79 | 3.37 | 5.20 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 81%
- 5 Years:
- 66%
- 3 Years:
- 59%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 124%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -6%
- 1 Year:
- -21%
RETURN ON EQUITY
- 10 Years:
- -2%
- 5 Years:
- 2%
- 3 Years:
- 3%
- Last Year:
- 5%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 24 | 24 | 24 | 24 | 24 | |
| 83 | 179 | 176 | 387 | 468 | 1,078 | 1,087 | 1,133 | 1,190 | 1,284 | |
| 81 | 0 | 0 | 2 | 6 | 42 | 81 | 83 | 89 | 84 | |
| Trade Payables | 1 | 3 | 5 | 1 | 2 | 6 | 13 | 18 | 45 | 34 |
| 18 | 7 | 10 | 25 | 71 | 39 | 70 | 49 | 59 | 56 | |
| Total Liabilities | 183 | 189 | 192 | 416 | 548 | 1,187 | 1,274 | 1,308 | 1,407 | 1,482 |
| 0 | 0 | 0 | 7 | 23 | 85 | 179 | 192 | 184 | 167 | |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 2 | 16 | 18 | 0 | 1 | 2 |
| 177 | 181 | 186 | 381 | 409 | 418 | 917 | 923 | 928 | 931 | |
| 0 | 0 | 0 | 4 | 5 | 4 | 7 | 14 | 18 | 27 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70 | 122 | 133 | |
| Cash & Bank | 0 | 4 | 1 | 11 | 87 | 7 | 90 | 63 | 57 | 139 |
| 5 | 3 | 5 | 12 | 24 | 657 | 63 | 47 | 96 | 84 | |
| Total Assets | 183 | 189 | 192 | 416 | 548 | 1,187 | 1,274 | 1,308 | 1,407 | 1,482 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1 | -3 | -1 | 2 | -7 | -16 | 13 | 8 | 47 | 62 | |
| Cash from Investing | 0 | -2 | -3 | -197 | -15 | -636 | 32 | -24 | -39 | -22 |
| Cash from Financing | -0 | 7 | 0 | 204 | 97 | 569 | -8 | -6 | -10 | -5 |
| -1 | 4 | -4 | 10 | 76 | -86 | 35 | -22 | -2 | 35 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-10 - Medplus Health Services Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'.
2026-09-10 - Medplus Health Services Limited has informed the Exchange regarding Outcome of Board Meeting held on September 10, 2026.
2026-08-18 - Medplus Health Services Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 17, 2026. Further, the company has informed the Exchange regarding voting results.
2026-08-17 - Medplus Health Services Limited has informed the Exchange regarding Summary Proceedings of Annual General Meeting held on August 17, 2026
2026-08-06 - Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
2026-08-05 - Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
2026-07-31 - Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
2026-07-26 - Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
2026-07-24 - Medplus Health Services Limited has informed the Exchange about Transcript
News
Recent coverage and analyst commentary for MEDPLUS
Loading news…
AI Stock Analyst
Medplus Health Services Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account